rs81002874
|
|
T |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
rs81002874
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
A review of targeted screening for prostate cancer: introducing the IMPACT study.
|
17419707 |
2007 |
rs81002874
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
Bayes analysis provides evidence of pathogenicity for the BRCA1 c.135-1G>T (IVS3-1) and BRCA2 c.7977-1G>C (IVS17-1) variants displaying in vitro splicing results of equivocal clinical significance.
|
20020529 |
2010 |
rs81002874
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group.
|
22711857 |
2012 |
rs81002874
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
Development and validation of a new algorithm for the reclassification of genetic variants identified in the BRCA1 and BRCA2 genes.
|
25085752 |
2014 |
rs81002874
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
Diagnostic Screening Workflow for Mutations in the BRCA1 and BRCA2 Genes.
|
25685387 |
2015 |
rs81002874
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
Elevated expression of Ki-67 identifies aggressive prostate cancers but does not distinguish BRCA1 or BRCA2 mutation carriers.
|
20043088 |
2010 |
rs81002874
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
Evaluation of a 5-tier scheme proposed for classification of sequence variants using bioinformatic and splicing assay data: inter-reviewer variability and promotion of minimum reporting guidelines.
|
23893897 |
2013 |
rs81002874
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
Functional classification of DNA variants by hybrid minigenes: Identification of 30 spliceogenic variants of BRCA2 exons 17 and 18.
|
28339459 |
2017 |
rs81002874
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer.
|
23569316 |
2013 |
rs81002874
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
Male breast cancer in a multi-gene panel testing cohort: insights and unexpected results.
|
28008555 |
2017 |
rs81002874
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
Molecular characterization and cancer risk associated with BRCA1 and BRCA2 splice site variants identified in multiple-case breast cancer families.
|
16211554 |
2005 |
rs81002874
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing.
|
22006311 |
2011 |
rs81002874
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
Novel and recurrent BRCA1/BRCA2 mutations in early onset and familial breast and ovarian cancer detected in the Program of Genetic Counseling in Cancer of Valencian Community (eastern Spain). Relationship of family phenotypes with mutation prevalence.
|
23479189 |
2013 |
rs81002874
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
Overexpression of RAD51 occurs in aggressive prostatic cancer.
|
20002770 |
2009 |
rs81002874
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
Prediction of BRCA1 and BRCA2 mutation status using post-irradiation assays of lymphoblastoid cell lines is compromised by inter-cell-line phenotypic variability.
|
17063265 |
2007 |
rs81002874
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
Predisposition gene identification in common cancers by exome sequencing: insights from familial breast cancer.
|
22527104 |
2012 |
rs81002874
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO.
|
12048272 |
2002 |
rs81002874
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis.
|
20736950 |
2010 |
rs81002874
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
The role of BRCA1 and BRCA2 in prostate cancer.
|
23747895 |
2013 |
rs81002874
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene.
|
12474142 |
2003 |